Co-Director of the Experimental Therapeutics Program
Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center
Los Angeles, CA
Dr. Mita joins the NCI Adult CIRB - Early Phase Emphasis board from the Cedars-Sinai Medical Center where she's the Co-Director of the Experimental Therapeutics Program at the Samuel Oschin Comprehensive Cancer Institute. Dr. Mita's research focuses on the development of early clinical trials of novel therapeutic agents. Dr. Mita has authored more than 75 articles published in peer reviewed publications. She has presented more than 90 abstracts and poster presentations and has lectured at numerous conferences and meetings.
In addition to being a member of the European Society for Medical Board in Internal medicine, Dr. Mita is a member of the American Society for Clinical Oncology, the American Association for Cancer Research and the Southwest Oncology Group, Breast and Early Therapeutics. She earned a diploma at the School of Breast Oncology in Atlanta, Georgia and both a merit award and the Brigid G. Leventhal Award from the American Cancer Society of Clinical Oncology.
After earning her medical degree at the Carol Davila University of Medicine and Pharmacy in Bucharest, Romania, Dr. Mita completed specialty training in oncology and cancer research at Paul Brousse Hospital in Villejuif, France and the Rene Huguenin Center in Saint-Cloud, France. She received additional specialty training in oncology at the Claudius Regaud Center, Purpan Hospital, the Saint-Antoine Hospital and Childrens Hospital, all in France. Dr. Mita performed a fellowship in Medical Oncology and one in Advanced Oncology Drug Development at the University of Texas Health Science Center in San Antonio.